TABLE 4.
HPV Group Prevalences for Women Included in This Study by Their Selection Criterion
| All N = 353 |
Group 1 N = 314 |
Group 2 N = 24 |
Group 3 N = 15 |
P | |
|---|---|---|---|---|---|
| Prevalence of vaginal HPV: | |||||
| All (%) | 42.5 | 44.0 | 12.5 | 60.0 | 0.02 |
| Prevalence of cervical HPV: | |||||
| All (%) | 33.7 | 36.0 | 8.3 | 26.7 | 0.06 |
| Ratio (V/C) | 1.3 | 1.2 | 1.5 | 2.2 | |
| Prevalence of vaginal HPV: | |||||
| α3/α15 (%) | 14.2 | 15.0 | 4.2 | 13.3 | 0.4 |
| Prevalence of cervical HPV: | |||||
| α3/α15 (%) | 7.7 | 8.3 | 0.0 | 6.7 | 0.4 |
| Ratio (V/C) | 1.8 | 1.8 | n/a | 2.0 | |
| Prevalence of vaginal HPV: | |||||
| α9/α11 (%) | 12.5 | 12.1 | 4.2 | 33.3 | 0.03 |
| Prevalence of cervical HPV: | |||||
| α9/α11 (%) | 15.0 | 15.9 | 4.2 | 13.3 | 0.4 |
| Ratio (V/C) | 0.8 | 0.8 | 1.0 | 2.5 |
Group 1: Carcinogenic HPV positive at the year 5–7 visit; Group 2: Carcinogenic HPV negative at the year 5–7 visit; Group 3: Became sexually active between the year 5–7 visit and this follow-up visit.